Position emission tomography of esophageal carcinoma using 11C-choline and 18F-fluorodeoxyglucose: A novel method of preoperative lymph node staging

Cancer

Volumn 86, Issue 9, 1999, Pages 1638-1648

  Kobori, Oichiro ^a   Kirihara, Yujiro ^a   Kosaka, Noboru ^a   Hara, Toshihiko ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

11C choline; 18F fluorodeoxyglucose; Carcinoma; Diagnosis; Esophagus; Lymph node; Positron emission tomography; Staging

Indexed keywords

CARBON 11; CHOLINE; FLUORODEOXYGLUCOSE F 18; CARBON; DIAGNOSTIC AGENT;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ESOPHAGUS CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; AGED; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ESOPHAGUS TUMOR; FEMALE; LYMPH NODE; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TIME;

AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CHOLINE; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033216658     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991101)86:9<1638::AID-CNCR4>3.0.CO;2-U     Document Type: Article

References (67)

1. Bogomoletz WV, Molas G, Gayet B, Potet F. Superficial squamous cell carcinoma of the esophagus: a report of 76 cases and review of the literature. Am J Surg Pathol 1989;13:535-46.
2. Goseki N, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma: a comparative study with gastric carcinoma. Cancer 1992;69:1088-93.
3. Sugimachi K, Ikebe M, Kitamura K, Toh Y, Matsuda H, Kuwano H. Long-term results of esophagectomy for early esophageal carcinoma. Hepatogastroenterology 1993;40: 203-6.
4. Rice TW, Zuccaro G Jr., Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 1998;65:787-92.
5. Murata Y, Muroi M, Yoshida M, Ide H, Hanyu F. Endoscopic ultrasonography in the diagnosis of esophageal carcinoma. Surg Endosc 1987;1:11-6.
6. Botet JF, Lightdale CJ, Zauber AG, Gerdes H, Urmacher C, Brennan MF. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology 1991;181:419-25.
7. Tio TL, Cohen P, Coene PP, Udding J, den Hartog Jager FCA, Tytgat GNJ. Endosonography and computed tomography of esophageal carcinoma: preoperative classification compared to the new (1987) TNM system. Gastroenterology 1989; 96:1478-86.
8. Tio TL, Coene PPLO, den Hartog Jager FCA, Tytgat GNJ. Preoperative TNM classification of esophageal carcinoma by endosonography. Hepatogastroenterology 1990;37: 376-81.
9. Heinz A, Wahl W, Mildenberger P, Braunstein S, Georg M, Junginger T. Endosonographie beim Oesophaguscarcinom: Ergebnisse einer klinischen Untersuchung und einer In-vitro-Analyse. Chirurg 1992;63:629-33.
10. Goldschmid S, Nord J. Endoscopic diagnosis and treatment of esophageal cancer. Esophagus 1994;4:827-50.
11. Luketich JD, Kim R, Landreneau RJ, Urso K, Ferson P, Lembersky B, et al. A comparison of endoscopic ultrasound and minimally invasive surgical staging in esophageal cancer (abstract). Am J Gastroenterol 1996;91:1892.
12. Natsugoe S, Yoshinaka H, Morinaga T, Shimada M, Baba M, Fukumoto T, et al. Ultrasonographic detection of lymphnode metastases in superficial carcinoma of the esophagus. Endoscopy 1996;28:674-9.
13. Luketich JD, Schauer PR, Meltzer CC, Landreneau RJ, Urso K, Townsend DW, et al. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 1997;64: 765-9.
14. Luketich JD, Schauer P, Urso K, Kassis E, Ferson P, Keenan R, et al. Future directions in esophageal cancer. Chest 1998; 113:120S-2S.
15. Block MI, Patterson GA, Sundaresan RS, Bailey MS, Flanagan FL, Dehdashti F, et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770-7.
16. 11C]choline. J Nucl Med 1997;38: 842-7.
17. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998;39:990-5.
18. 18F]2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978;19:1154-61.
19. 18F]FDG by the tetrabutylammonium method: achievement of high yield, purity, reproducibility, reliability, and safety. Appl Radiat Isot 1997;48:201-5.
20. 11C]choline, a positron-emitting tracer for tumor imaging. Appl Radiat Isot 1999;50:531-3.
21. Zanzonico PB, Brill AB, Becker DV. Radiation dosimetry. In: Wagner HN Jr., Szabo Z, Buchanan JW, editors. Principles of nuclear medicine. 2nd ed. Philadelphia: Saunders, 1995: 106-34.
22. Japanese Society for Esophageal Diseases. Guidelines for the clinical and pathological studies on carcinoma of the esophagus [in Japanese]. 8th ed. Tokyo: Kanehara Shuppan, 1992.
23. Lowe VJ, DeLong DM, Hoffman JM, Coleman RE. Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. J Nucl Med 1995;36:883-7.
24. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
25. Yamada A, Kobayashi S. Diagnosis and treatment of early esophageal carcinoma. Zentralbl Chir 1985;110:1399-413.
26. Sugimachi K, Ohno S, Matsuda H, Mori M, Matsuoka H, Kuwano H. Clinicopathologic study of early stage esophageal carcinoma. Br J Surg 1989;76:759-63.
27. Sugimachi K, Kitamura K, Matsuda H, Mori M, Kawano H, Ide H. Proposed new criteria for early carcinoma of the esophagus. Surg Gynecol Obstet 1991;173:303-8.
28. Haruma K, Tokutomi T, Tsuda T, Yoshihara M, Sumii K, Kajiyama G. Superficial esophageal carcinoma: a report of 27 cases in Japan. Am J Gastroenterol 1991;86:1723-8.
29. Nabeya K, Hanaoka T, Li S, Nyumura T. What is the ideal treatment for early esophageal cancer? Endoscopy 1993;25: 670-1.
30. Sabik JF, Rice TW, Goldblum JR, Koka A, Kirby TJ, Mendendorp SV, et al. Superficial esophageal carcinoma. Ann Thorac Surg 1995;60:896-902.
31. Endo M, Kawano T. Detection and classification of early squamous cell esophageal cancer. Dis Esophag 1997; 10:155-8.
32. Hennessy TP, O'Connel R. Carcinoma of the hypopharynx, esophagus and cardia. Surg Gynecol Obstet 1986;162:243-7.
33. Mannell A, Becker PJ. Evaluation of the results of oesophagectomy for oesophageal cancer. Br J Surg 1991;78:36-40.
34. Akiyama H, Tsurumaru M, Kawamura T, Ono Y. Principles of surgical treatment for carcinoma of the esophagus. Ann Surg 1981;194:438-46.
35. Kato H, Watanabe H, Tachimori Y, Iizuka T. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 1991;51:931-5.
36. Isono K, Onoda S, Ishikawa T, Seto H, Nakayama K. Studies on the causes of deaths from esophageal carcinoma. Cancer 1982;49:2173-9.
37. Turner GG. Excision of the thoracic oesophagus for carcinoma, with construction of an extra-thoracic gullet. Lancet 1933;2:1315-6.
38. Stelzner F. Die abdomino-cervicale Oesophagektomie. Langenbecks Arch Chir 1981;355:63-8.
39. Orringer MB. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 1984;200:282-8.
40. Rothmund M, Gamstätter G. Standardisierte Chirurgie des Ösophaguskarcinoms. Dtsch Med Wsch 1984;109:606-12.
41. Ulrich B, Grabitz K, Kockel N. Ergebnisse der Magenhochzugsoperation ohne Thoracotomie bei der Behandelung des forgeschrittenen Ösophaguskarcinoms. Zbl Chir 1984;109: 1032-43.
42. Goldfaden D, Orringer M, Appelmann HD, Kalish R. Adenocarcinoma of the distal esophagus and gastric cardia. J Thorac Cardiovasc Surg 1986;91:242-7.
43. Röher HD, Linn RM, Stahlknecht CD, Thon KP. Zur operativen Verfahrenswahl beim Ösophaguskarcinom. Chirurg 1988;59:582-6.
44. Barbier PA, Becker CD, Wagner HE. Esophageal carcinoma: patient selection for transhiatal esophagectomy: a prospective analysis of 50 consecutive cases. World J Surg 1988;12: 263-9.
45. Finley RJ, Incluet RI. The results of esophagastrectomy without thoracotomy for adenocarcinoma of the esophagogastric junction. Ann Surg 1989;210:535-43.
46. Hankins JR, Attar S, Coughlin TR, Miller JE, Hebel JR, Suter CM, et al. Carcinoma of the esophagus: a comparison of the results of transhiatal versus transthoracic resection. Ann Thorac Surg 1989;47:700-5.
47. Tilanus HW, Hop WCJ, Langenhorst BLAM, van Lanschot JJB. Esophagectomy with or without thoracotomy: is there any difference? J Thorac Cardiovasc Surg 1993;105:898-903.
48. Horstmann O, Verreet PR, Becker H, Ohmann C, Röher HD. Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer. Eur J Surg 1995;161:557-67.
49. Quint LE, Glazer GM, Orringer MB, Gross BH. Esophageal carcinoma: CT findings. Radiology 1985;155:171-5.
50. Quint LE, Glazer GM, Orringer MB, Esophageal imaging by MR and CT: study of normal anatomy and neoplasms. Radiology 1985;156:727-31.
51. Becker CD, Barbier P, Porcellini B. CT evaluation of patients undergoing transhiatal esophagectomy for cancer. J Comput Assist Tomogr 1986;10:607-11.
52. Krasna MJ. Advances in staging of esophageal carcinoma. Chest 1998;113:107S-11S.
53. Krasna MJ, Flowers JL, Attar S, McLaughlin JS. Combined thoracoscopic/laparoscopic staging of esophageal cancer. J Thorac Cardiovasc Surg 1996;111:800-7.
54. Hara T, Kosaka N, Kondo T, Kishi H, Kobori O. Imaging of brain tumor, lung cancer, esophagus cancer, colon cancer, prostate cancer, and bladder cancer with [C-11]choline [abstract]. J Nucl Med 1997;38:250.
55. Clavo AC, Brown RS, Wahl RL. Fluorodeoxyglucose uptake in human cancer cell lines is increases by hypoxia. J Nucl Med 1995;36:1625-32.
56. Minn H, Clavo AC, Wahl RL. Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: in vitro evaluation for PET imaging. Nucl Med Biol 1996;23:941-6.
57. Gulledge CJ, Dewhirst MW. Tumor oxygenation: a matter of supply and demand. Anticancer Res 1996;16:741-9.
58. Dang CV, Lewis BC, Dolde C, Dang G, Shim H. Oncogenes in tumor metabolism, tumorigenesis, and apoptosis. J Bioenerg Biomembr 1997;29:345-54.
59. Muthupala SP, Rempel A, Pedersen PL. Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr 1997;29:339-43.
60. Waki A, Fujibayashi Y, Yonekura Y, Sadato N, Ishii Y, Yokoyama A. Reassessment of FDG uptake in tumor cells: high FDG uptake as a reflection of oxygen-independent glycolysis dominant energy production. Nucl Med Biol 1997; 24:665-70.
61. Warden CH, Friedkin M. Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J Biol Chem 1985;260:6006-11.
62. Macara IG. Elevated phosphocholine concentration in rastransformed NIH 3T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown. Mol Cell Biol 1989;9:325-8.
63. Teegarden D, Taparowsky EJ, Kent C. Altered phosphatidylcholine metabolism in C3H10T[1/2] cells transfected with the Harvey-ras oncogene. J Biol Chem 1990;265: 6042-7.
64. 13C-NMR studies of choline and ethanolamine uptake. Biochim Biophys Acta 1991;1095:5-16.
65. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR application of the zero trans method. Anticancer Res 1996;16: 1375-80.
66. Aiken NR, Gillies RJ. Phosphomonoester metabolism as a function of all proliferative status and exogenous precursors. Anticancer Res 1996;16:1393-7.
67. Funagalli U. Resective surgery for cancer of the thoracic esophagus: results of a consensus conference held at the Sixth World Congress of the International Society for Diseases of the Esophagus. Dis Esoph 1996;9(Suppl 1): 30-8.